{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:40:44Z","timestamp":1786984844637,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.atherosclerosis.2014.01.015","type":"journal-article","created":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T00:45:20Z","timestamp":1392165920000},"page":"146-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Non-HDL cholesterol is an independent risk factor for aspirin resistance in obese patients with type 2 diabetes"],"prefix":"10.1016","volume":"234","author":[{"given":"Jong Dai","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kue Jeong","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hyoung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Mook","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Goo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9899-4992","authenticated-orcid":false,"given":"Byung Wan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4882-1206","authenticated-orcid":false,"given":"Ji Oh","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Kyong","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joong Yeol","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2014.01.015_bib1","first-page":"408","article-title":"Epidemiology of diabetic dyslipidemia","volume":"3","author":"Laakso","year":"1995","journal-title":"Diabetes Rev"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2014.01.015_bib2","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.2337\/diacare.21.7.1138","article-title":"Mortality in adults with and without diabetes in a national cohort of the US population, 1971\u20131993","volume":"21","author":"Gu","year":"1998","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.01.015_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.01.015_bib4","first-page":"S11","article-title":"Standards of medical care in diabetes","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"issue":"7329","key":"10.1016\/j.atherosclerosis.2014.01.015_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"issue":"7637","key":"10.1016\/j.atherosclerosis.2014.01.015_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.39430.529549.BE","article-title":"Aspirin \u201cresistance\u201d and risk of cardiovascular morbidity: systematic review and meta-analysis","volume":"336","author":"Krasopoulos","year":"2008","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.01.015_bib7","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1681\/ASN.V451159","article-title":"Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group","volume":"4","author":"Levey","year":"1993","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.01.015_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4093\/dmj.2011.35.5.431","article-title":"2011 clinical practice guidelines for type 2 diabetes in Korea","volume":"35","year":"2011","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.atherosclerosis.2014.01.015_bib9","series-title":"The Asia-Pacific perspective: redefining obesity and its treatment","author":"WHO West Pacific Region","year":"2000"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.01.015_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jacc.2012.11.009","article-title":"Remnant cholesterol: \u201cnon-(HDL-C\u00a0+\u00a0LDL-C)\u201d as a coronary artery disease risk factor","volume":"61","author":"McPherson","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2014.01.015_bib11","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.2337\/diabetes.54.8.2430","article-title":"Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment","volume":"54","author":"Angiolillo","year":"2005","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.01.015_bib12","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1210\/jc.2009-2392","article-title":"Aspirin resistance is associated with glycemic control, the dose of aspirin, and obesity in type 2 diabetes mellitus","volume":"95","author":"Ertugrul","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.01.015_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4093\/kdj.2008.32.1.53","article-title":"Prevalence and clinical characteristics of aspirin resistance in the patients with type 2 diabetes mellitus","volume":"32","author":"Kang","year":"2008","journal-title":"Korean Diabetes J"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2014.01.015_bib14","first-page":"1731","article-title":"Effect of polymorphism and type II diabetes on aspirin resistance in patients with unstable coronary artery disease","volume":"124","author":"Gao","year":"2011","journal-title":"Chin Med J"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2014.01.015_bib15","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/01.CIR.0000013777.21160.07","article-title":"Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events","volume":"105","author":"Eikelboom","year":"2001","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.01.015_bib16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","article-title":"A\u00a0prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2014.01.015_bib17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.amjmed.2006.10.021","article-title":"Aspirin resistance and adverse clinical events in patients with coronary artery disease","volume":"120","author":"Chen","year":"2007","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2014.01.015_bib18","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1111\/j.1538-7836.2010.04017.x","article-title":"High on-aspirin platelet reactivity as measured with aggregation-based, cyclooxygenase-1 inhibition sensitive platelet function tests is associated with the occurrence of atherothrombotic events","volume":"8","author":"Breet","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.01.015_bib19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1001\/jamaneurol.2013.601","article-title":"Association of aspirin resistance with increased stroke severity and infarct size","volume":"70","author":"Zheng","year":"2013","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.01.015_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000315147","article-title":"Biochemical aspirin resistance and recurrent lesions in patients with acute ischemic stroke","volume":"64","author":"Jeon","year":"2010","journal-title":"Eur Neurol"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2014.01.015_bib21","first-page":"1979","article-title":"Aspirin resistance in patients with acute ischemic stroke","volume":"258","author":"Ozben","year":"2011","journal-title":"J\u00a0Neurol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2014.01.015_bib22","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/hrt.2010.220491","article-title":"High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention","volume":"97","author":"Breet","year":"2011","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.01.015_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00592-005-0186-y","article-title":"Prevalence of aspirin resistance in patients with type 2 diabetes","volume":"42","author":"Fateh-Moghadam","year":"2005","journal-title":"Acta Diabetol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.01.015_bib24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/13685538.2012.666584","article-title":"The prevalence, risk factors and prognosis of aspirin resistance in elderly male patients with cardiovascular disease","volume":"15","author":"Cao","year":"2012","journal-title":"Aging Male"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.01.015_bib25","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.diabres.2010.07.008","article-title":"Clinical determinants of aspirin resistance in diabetes","volume":"90","author":"Yassine","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.01.015_bib26","doi-asserted-by":"crossref","first-page":"636","DOI":"10.5301\/JN.2011.6259","article-title":"Aspirin resistance in patients with chronic renal failure","volume":"24","author":"Tanrikulu","year":"2011","journal-title":"J Nephrol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.01.015_bib27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9149(01)01631-9","article-title":"Profile and prevalence of aspirin resistance in patients with cardiovascular disease","volume":"88","author":"Gum","year":"2001","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.01.015_bib28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jdiacomp.2007.05.002","article-title":"Aspirin resistance associated with HbA1c and obesity in diabetic patients","volume":"22","author":"Cohen","year":"2008","journal-title":"J\u00a0Diabetes Complications"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.01.015_bib29","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/ndt\/gfr476","article-title":"High frequency of aspirin resistance in patients with nephrotic syndrome","volume":"27","author":"Akoglu","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2014.01.015_bib30","article-title":"A\u00a0study of aspirin resistance in type 2 diabetes","volume":"106","author":"Singla","year":"2008","journal-title":"J\u00a0Indian Med Assoc"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.01.015_bib31","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.amjcard.2009.04.027","article-title":"Aspirin resistance in healthy drug-naive men versus women (from the Heredity and Phenotype Intervention Heart Study)","volume":"104","author":"Shen","year":"2009","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.01.015_bib32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clineuro.2007.09.005","article-title":"Can aspirin resistance be clinically predicted in stroke patients?","volume":"110","author":"Seok","year":"2008","journal-title":"Clin Neurol Neursurg"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.01.015_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1467-789X.2011.00930.x","article-title":"Platelet activation in obesity and metabolic syndrome","volume":"13","author":"Santilli","year":"2013","journal-title":"Obes Rev"},{"issue":"50","key":"10.1016\/j.atherosclerosis.2014.01.015_bib34","doi-asserted-by":"crossref","first-page":"52526","DOI":"10.1074\/jbc.M407407200","article-title":"Binding of low density lipoprotein to platelet apolipoprotein E receptor 2\u2032 results in phosphorylation of p38MAPK","volume":"279","author":"Korporaal","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2014.01.015_bib35","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1161\/ATVBAHA.107.150698","article-title":"Platelet activation by oxidized low-density lipoprotein is mediated by CD36-scavenger receptor A complex","volume":"27","author":"Korporaal","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.01.015_bib36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11239-007-0154-1","article-title":"Effect of high dose statin therapy on platelet function; statins reduce aspirin-resistant platelet aggregation in patients with coronary heart disease","volume":"27","author":"Tirnaksiz","year":"2009","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.01.015_bib37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.atherosclerosis.2010.10.006","article-title":"Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia","volume":"214","author":"Puccetti","year":"2011","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.01.015_bib38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2337\/diacare.26.1.16","article-title":"Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study","volume":"26","author":"Lu","year":"2003","journal-title":"Diabetes Care"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014000392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014000392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:35:13Z","timestamp":1758155713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915014000392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0021915014000392"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.01.015","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-HDL cholesterol is an independent risk factor for aspirin resistance in obese patients with type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}